Literature DB >> 20402754

Four novel CYP27A1 mutations in seven Italian patients with CTX.

G N Gallus1, M T Dotti, A Mignarri, A Rufa, P Da Pozzo, E Cardaioli, A Federico.   

Abstract

BACKGROUND AND
PURPOSE: Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disease, because of sterol 27-hydroxylase deficiency. Clinical manifestations of CTX are tendon xanthomas, juvenile cataracts, osteoporosis, diarrhoea and multiple progressive neurological dysfunctions. More than 300 patients with CTX have been reported to date worldwide and about fifty different mutations identified in CYP27A1 gene. This study describes the clinical and laboratory findings of seven new patients.
METHODS: We report the molecular and clinical characterization of seven new Italian patients with CTX carrying four novel mutations.
RESULTS: We identified four novel mutations located in different exons, in particular in the region of exons 2-5 of the CYP27A1 gene. Phenotypical expression did not differ from classical CTX presentation except for absence of tendon xanthomas in two patients.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20402754     DOI: 10.1111/j.1468-1331.2010.03002.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  2 Novel deletions of the sterol 27-hydroxylase gene in a Chinese Family with Cerebrotendinous Xanthomatosis.

Authors:  Di Tian; Zai-Qiang Zhang
Journal:  BMC Neurol       Date:  2011-10-21       Impact factor: 2.474

2.  A useful multi-analyte blood test for cerebrotendinous xanthomatosis.

Authors:  Andrea E DeBarber; Jenny Luo; Roberto Giugliani; Carolina F M Souza; John Pei-Wen Chiang; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Clin Biochem       Date:  2014-04-21       Impact factor: 3.281

3.  Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.

Authors:  Chen Chen; Yue Zhang; Hui Wu; Yi-Min Sun; Ye-Hua Cai; Jian-Jun Wu; Jian Wang; Ling-Yun Gong; Zheng-Tong Ding
Journal:  Metab Brain Dis       Date:  2017-06-17       Impact factor: 3.584

4.  Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Authors:  Yoshiki Sekijima; Shingo Koyama; Tsuneaki Yoshinaga; Masayoshi Koinuma; Yuji Inaba
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

Review 5.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

Review 6.  Cytochromes p450: roles in diseases.

Authors:  Irina A Pikuleva; Michael R Waterman
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

7.  A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns.

Authors:  Andrea E DeBarber; Jenny Luo; Michal Star-Weinstock; Subhasish Purkayastha; Michael T Geraghty; John Pei-Wen Chiang; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  J Lipid Res       Date:  2013-11-02       Impact factor: 5.922

Review 8.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Authors:  Shuke Nie; Guiqin Chen; Xuebing Cao; Yunjian Zhang
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

9.  Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Authors:  Lan-Xiao Cao; Mi Yang; Ying Liu; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

10.  Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method.

Authors:  Lisa Bleyle; Hidde H Huidekoper; Frederic M Vaz; Renu Singh; Robert D Steiner; Andrea E DeBarber
Journal:  Mol Genet Metab Rep       Date:  2016-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.